Project Grant R21AR084042
Award Date
9/26/23
Completion Date
8/31/25
Dollars Obligated
$753K
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98101, USA
Similar Awards
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director, under the Trans-NIH Research Support program (CFDA 93.310), provides $486,750 to The Children's Hospital Corporation (doing business as Boston Children's Hospital) to establish collaborations and capabilities to advance the study of the exposome in childhood-onset rheumatic diseases and other pediatric autoimmune conditions. The key products and services to be delivered include: Establishing a...
The University of Colorado-Denver received a $449,000 exploratory and developmental research project grant (R21) from the National Institutes of Health (NIH) under the Trans-NIH Research Support (CFDA 93.310) program. The grant aims to plan a future national, interdisciplinary, collaborative research network to study the exposome in autoimmune diseases, specifically rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Key activities include conducting a landscape analysis of...
This $1,559,700 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) funds research by the Benaroya Research Institute at Virginia Mason (BRI) to investigate how genetic and epigenetic factors influence T cell function in autoimmune diseases. The key objectives are to: 1) use CRISPR-interference screening to identify regulatory regions that impact T cell proliferation and migration, 2) apply single-cell...
The Regents of the University of Colorado, doing business as the University of Colorado-Denver, received a $451,938 Project Grant award from the National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310) on September 22, 2023. The funding supports the establishment of the "Pediatric Autoimmune Consortium for Exposome Research (PACER)," a new transdisciplinary research team focused on developing the infrastructure needed for a future large-scale study on the...
This Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program provides $102,399 to Wright State University to study the role of extracellular, UV-damaged DNA in promoting systemic inflammatory responses in photosensitive autoimmune disorders like lupus. The key objectives are to: 1) Demonstrate the presence of cyclobutane pyrimidine dimers (CPDs) in extracellular vesicles and correlate this with lupus disease...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $709,019 to the Benaroya Research Institute at Virginia Mason to study the role of the FOXP3 isoform in the development of systemic lupus erythematosus (SLE). The research aims to determine how the expression of the FOXP3 exon 2 isoform affects regulatory T cell function and contributes to the loss of immune...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $555,774 to the University of Alabama at Birmingham (UAB) to conduct research on the role of the aryl hydrocarbon receptor (AhR) pathway in suppressing T-bet+ B cells in systemic lupus erythematosus (SLE). The key objectives are to: 1) determine if AhR is required to inhibit the development of T-bet+ B cells in mice...
This $310,877 National Science Foundation project grant funds research on co-production of knowledge about autoimmunity between healthcare practitioners and patients. The grant supports ethnographic study of individual narratives of autoimmune disease through interviews and online community observation. The goal is to understand how functional medicine, an integrative treatment approach, conceptualizes autoimmunity and addresses it through attention to patient narratives and biographies. Yale...
This Cooperative Agreement award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $619,346.00 to the University of California, Los Angeles (UCLA) to delineate the epigenetic and transcriptional mechanisms underlying chronicity in autoimmune endocrinopathies. The principal project will determine if the epigenetic regulator UTX plays a role in the conversion of stem-like progenitor CD8+ T cells to effectors in...
This Project Grant award of $652,915, funded by the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program, aims to develop an innovative Spatial and Contextual Exposome Semantic Data Integration System (SPACESCANS). The key products and services to be delivered include: An ontology-annotated knowledge graph of existing high-quality spatial and contextual exposome data from heterogeneous public sources. A user-friendly data integration...